For many of the almost 40 million people in the U.S. who live with diabetes, monitoring blood sugar levels multiple times a day can make the difference between good health and serious heart, kidney, ...

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings ...

The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA clearance on April 10 for adults with ...

Dexcom has been cash flow positive for since 2014 and more recently moved into positive earnings territory. While revenue has grown very quickly, research and development expenses and selling, general ...

Dexcom stock surged Thursday after the Food and Drug Administration cleared its newest diabetes device for an extended 15-day ...

Investors feel optimistic about Abbott's robust strength in the EPD, Diabetes and Nutrition businesses. However, unfavorable forex impacts are concerning.

In a world where diabetes management is evolving at a rapid pace, the spotlight shines on non-invasive glucose monitors that ...

DexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use glucose ...

The 3-year-old male pug has been wearing the 'continuous glucose monitor', or CGM, sensor since he was admitted to the veterinary hospital at Parel on Friday. The CGM is a circular patch pinned on ...

Medicare Part B can cover a continuous glucose monitor (CGM), which offers a less invasive way of monitoring your blood sugar. If you’re enrolled in a Medicare Advantage (Part C) plan instead of ...

“Despite the addition of continuous glucose monitoring, we know that this is not enough to get people to a level of glycemia to prevent long-term complications. We also know that there is ...

The letter also noted that the company does not monitor how acetaminophen affects glucose sensing with its G7 monitors. The FDA also said Dexcom is not properly evaluating the risk of using the G6 ...